1,3-Dimethylimidazolidinone (DMI) Market Intelligence Report (May 27, 2026)

I. Market Price Dynamics
- Recent Quotations:
- On May 25, 2026, Shanghai Nuotai Chemical Co., Ltd. quoted 'price upon negotiation'; total supply volume and shipping address were not disclosed.
- On May 22, 2026, Shanghai Jieshikai Biotechnology Co., Ltd. offered 1,3-dimethylimidazolidinone (purity ≥99.0%) at RMB 59 per bottle (package specification unspecified).
- On May 24, 2026, a supplier in Tianmen City, Hubei Province quoted RMB 1 per kilogram (specification unspecified—likely for small-batch or specialty-grade material).
- On May 22, 2026, Shanghai Tongyuan Chemical Co., Ltd. quoted RMB 12 per kilogram (domestically produced; purity not specified).

- Price Volatility Analysis:
- Significant price dispersion reflects variations in purity grade, packaging specifications, and supplier pricing strategies. High-purity (≥99.0%) products command premium pricing, whereas lower-purity or small-batch offerings are priced substantially lower.
- The absence of a unified pricing benchmark across the market indicates substantial room for buyer–seller negotiation, potentially signaling regional supply–demand imbalances or channel-specific disparities.

II. Supply–Demand Dynamics
- Supply Side:
- Capacity Expansion: In 2026, three leading enterprises—Jiangsu Zhongdan Chemical, Zhejiang Huangma Technology, and Shandong Xinhua Chemical—collectively added 12,000 metric tons/year of high-purity (≥99.95%) DMI production capacity. Notably, Zhongdan Chemical’s Phase II electronic-grade production line (5,000 tons/year) at its Zhenjiang base commenced operations in March 2026, alleviating import dependency (import reliance stood at 31.4% in 2025).
- Industrial Distribution: Major domestic suppliers include Hebei Kangzhuang Environmental Protection Technology, Jingzhou Tianhe Chemical Technology, and Hubei Jingzhou Huabang Chemical. Production capacity is highly concentrated, with the top five firms accounting for 77.7% of total market share (CR5).

- Demand Side:
- Policy-Driven Demand: The National Medical Products Administration’s (NMPA) “Guidelines for Green Solvent Use in Chemical Pharmaceuticals (Trial)” — effective since January 2026 — explicitly lists DMI among priority-recommended solvents, promoting its adoption as a replacement for conventional solvents such as NMP and DMF in active pharmaceutical ingredient (API) synthesis. The substitution rate is projected to rise from 22% to over 35%.
- Downstream Applications:
Electronics: Used in solid-state electrolytes (e.g., co-formulated with LiTFSI to enhance lithium-ion transference number), purification of vapor-deposition sources for flexible OLEDs, and as a spinning aid in carbon fiber precursor production. A collaborative project between Xinhua Chemical and Ningbo Institute of Materials Technology & Engineering (Chinese Academy of Sciences) on DMI as a solid-state battery additive has successfully completed laboratory-scale trials; ton-scale validation is scheduled for 2027.
Pharmaceuticals: As a key synthetic intermediate in drug manufacturing, demand is steadily growing amid global pharmaceutical industry recovery and China’s pharmaceutical manufacturing upgrading.
New Energy: Increasing demand from lithium-ion battery electrolyte formulations represents one of DMI’s largest consumption segments.

III. Competitive Landscape
- Industry Concentration:
- In 2025, Hebei Kangzhuang Environmental Protection Technology ranked first with sales revenue of RMB 316 million, commanding a 32.0% market share. Jingzhou Tianhe Chemical Technology (15.0%) and Hubei Jingzhou Huabang Chemical (12.3%) ranked second and third, respectively. The top five players collectively held 77.7% of market share, reflecting markedly heightened concentration.
- Technical Barriers:
- Electronic-grade DMI imposes stringent requirements: total metallic impurities (Na?, K?, Fe3?) ≤50 ppb; moisture content ≤50 ppm; and particle count (≥0.5 μm) ≤5 particles/mL. Only Zhongdan Chemical, Huangma Technology, and Xinhua Chemical have obtained SEMI S2 certification and achieved mass production, establishing a de facto market entry barrier.

IV. Policy & Industry Environment
- Policy Support:
- The Ministry of Industry and Information Technology’s (MIIT) “Catalogue of Priority Applications for First-Batch New Materials (2025 Edition)” classifies DMI as a critical supporting material under the category of high-purity electronic solvents, offering insurance premium subsidies for first-of-a-kind equipment/systems and first-batch applications (up to RMB 8 million per project).
- A joint notice issued by the Ministry of Finance and the State Taxation Administration—“Announcement on the VAT Additional Deduction Policy for Advanced Manufacturing Enterprises”—includes DMI producers within the scope of advanced foundational chemical materials manufacturing, permitting an additional 5% deduction against payable VAT based on current deductible input VAT (in 2025, this policy reduced tax liabilities by approximately RMB 126 million across China’s top five DMI producers).
- Environmental Regulations:
- The Ministry of Ecology and Environment’s “Technical Guidelines for Environmental Risk Assessment of Chemical Substances (Trial)” exempts DMI from mandatory PBT (Persistent, Bioaccumulative, and Toxic) assessment, thereby shortening environmental impact assessment (EIA) approval timelines for new projects—from an average of 142 working days in 2025 to just 89 working days.

V. Future Outlook
1. Price Trends:
- Short-Term: Increased supply from newly commissioned capacity and accelerated import substitution may exert downward pressure on prices; however, high-purity grades will retain pricing power due to technical barriers.
- Long-Term: Expanding downstream applications—including solid-state batteries and flexible displays—and sustained policy incentives are expected to drive structural demand growth, supporting an upward shift in the overall price baseline.

2. Supply–Demand Balance:
- Supply Side: Accelerated capacity expansion by industry leaders and deepening domestic substitution will further reduce import reliance.
- Demand Side: Robust growth across electronics, pharmaceuticals, and new energy sectors is projected to lift China’s DMI market size to RMB 1.4 billion in 2026, representing a 9.4% year-on-year increase; electronic-grade and pharmaceutical-grade products are expected to account for over 65% of total market volume.

3. Competitive Structure:
- Market concentration will continue rising, with technology capability, regulatory certifications, and customer qualification becoming decisive competitive advantages. New entrants face formidable barriers.
- Leading enterprises will consolidate their positions through end-to-end quality control—including ultra-high-purity refining processes and ultra-clean filling lines—while SMEs may either specialize in niche segments or exit the market.

4. Technological Development:
- Green Manufacturing: Widespread adoption of eco-friendly catalysts and continuous production technologies to reduce energy consumption and emissions.
- Process Efficiency: Optimization of reaction pathways and equipment design to improve yield and selectivity, thereby lowering production costs.
- Intelligent Automation: Deployment of automated production lines and intelligent control systems to enhance operational efficiency and product quality consistency.